Healthlead PCL (BKK:HL) FFO


BKK:HL Healthlead PCL BKK:HL
76 GF Score
Price ฿5.60
GF Value ฿10.82
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL FFO?

FFO (Funds from operations) only applies to REITs.

BKK:HL
76GF Score
Healthlead PCL BKK:HL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿5.60 is trading 48.2% below its estimated GF Value™ of ฿10.82. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • FFO:
  • GF Value™: ฿10.82 vs. price of ฿5.60 (48.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
76GF Score

Get the complete analysis for BKK:HL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.60
Price
฿10.82
GF Value